Vince Colucci, Pharm.D., BCPS
Vince Colucci, Pharm.D., BCPS
• Quality Management/Outcomes Improvement
• Pharmacy-Driven Ambulatory Drug Management Programs
• (Anticoagulation, Vaccination/Immunization, CHF Clinic)
• Critical Care
• Cardiovascular Care
• Sports Pharmacy
• Medicine/Ergogenic Aids
• Pharm.D. from Idaho State University, Pocatello, ID (High Honors)
• B.S. in Pharmacy from The University of Montana, Missoula, MT (Honors)
• Licensed Pharmacist 1982-present
• Board Certified Pharmacotherapy Specialist (AQ Cardiology) 1990-present
• ECLIPSE Bridging Study
BRIDGE ECLIPSE Bridging Study
Colucci VJ, Berry BD. Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy. Ann Pharmacother 2008 Jun;42(6):882-887. Epub 2008 Apr 29.
Colucci VJ. Travel medicine and pharmacy: How big a role can we play? In: Drug Store News (Kenlon J, Ed.) New York, NY:Lebhar-Friedman. May/June 2007:17-22.
Howard PA, Cheng JW, Crouch MA, Colucci VJ, Kalus JS, Spinler SA, Munger M. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure. Ann Pharmacother 2006 Sep;40(9):1607-1617. Epub 2006 Aug 8. Review.
Colucci VJ, Rivey MP. Potential contribution of long-term rofecoxib in a patient with cardiogenic syncope and ischemic stroke. J Pharm Technol 2006;22:174-178.
Colucci, VJ. Book Review: Physical Activity Epidemiology, Dishman RK, Washburn RA, Heath GW. (Human Kinetics, Champaign, IL, 2004). Ann Pharmacother 2004;38:2188.
Lienemann AO, Colucci VJ, Jones MS, Trauscht JM. Treatment of palmoplantar keratoderma with continuous infusion 5-fluorouracil. Cutis 2004 May;73(5):303-308.
Colucci VJ, Allington DR. Hypothermia and frostbite. US Pharmacist December 2002:H36-H43.
Colucci VJ, Allington DR. Acute mountain sickness. US Pharmacist July 2002:60-66.
Colucci VJ. Book Review: Sport and Exercise Pharmacology, Reents S; (Human Kinetics, Champaign IL, 2000). Ann Pharmacother 2001;35:1500-1501.
Colucci VJ, Knapp JF. Increase in international normalized ratio associated with smoking cessation. Ann Pharmacother 2001 Mar;35(3):385-386.
Colucci VJ, Rivey MP. Tolterodine-warfarin drug interaction. Ann Pharmacother. 1999 Nov;33(11):1173-1176.
Peterson JP, Colucci VJ, Schiff SE. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs. Am J Hosp Pharm 1991 Sep;48(9):1962-1964.
Abstracts and Posters
Colucci VJ, Moore D, Barta D, Harris H, Helgerson S. Montana Infectious Disease Network and Oracle (MIRACLE) – POSTER. Presented at the 2008 Bioterrorism Training and Curriculum Development Awardees Conference. Rockville, MD. April 2008.
Hall E, Allington DR, Colucci VJ. Community Capability Assessment Tool (POSTER). Development of an Preparedness Assessment Instrument. Public Health Preparedness Summit. Washington, DC, 2007.
Hughson HE, Colucci VJ, Mead CE, Gardner PR, Risi GR, Overholtzer DA, et al. (POSTER). An Academic Detailing Initiative to Optimize the Use of Antimicrobials in Acute Bacterial Rhino-Sinusitis and Pharyngitis in Ambulatory Care Patients at a Multispecialty Ambulatory Clinic. ACCP 2003 Annual Meeting. Atlanta, GA. November 03, 2003.
Colucci VJ, Mead CE. (POSTER). Accuracy of the Coaguchek S and the Coaguchek Point of Care testing devices Compared to a Standard Laboratory Instrument. ACCP 2002 Annual Meeting. Albuquerque, NM. October 22, 2002.
Colucci V, Overholtzer D. (POSTER). Effectiveness of an Anticoagulation Management Service in a Multispecialty Ambulatory Care Clinic. ASHP Midyear Clinical Meeting. Las Vegas, NV. December 3, 2000.
Peterson J, Colucci V. Pharmacy-lab interface: Use of abnormal laboratory results as a screen for inappropriate dosage of renally eliminated drugs. Presented at the ACCP Eleventh Annual Meeting, Aug 5-8, 1990.